Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
The nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD encompasses a wide histological spectrum ranging from benign simple steatosis to non-Alcoholic steatohepatitis (NASH). Sustained inflammation in the liver is critical in this process. Hepatic m...
Guardado en:
| Autores principales: | Chackelevicius, Carla Melisa, Gambaro, Sabrina Eliana, Tiribelli, Claudio, Rosso, Natalia |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/96722 https://ri.conicet.gov.ar/11336/62898 https://www.wjgnet.com/1007-9327/full/v22/i41/9096.htm |
| Aporte de: |
Ejemplares similares
-
Fosinopril improves liver fibrosis by upregulating ACE2/Angiotensin-(1-7) axis activation in rats with nonalcoholic steatohepatitis
por: Liu, Bo, et al.
Publicado: (2012) -
Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
por: Sookoian, S., et al. -
Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease
Publicado: (2017) -
Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis
por: Gonzalez Polo, Virginia, et al.
Publicado: (2019) -
Fatty liver disease, a silent killer of human beings /
por: Saha, Ashis Kumar
Publicado: (2020)